Skip to main content

Table 6 Glucose abnormalities in relation to antipsychotic treatment.

From: Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

 

Diabetes (n = 26)

Prediabetes (n = 97)

Normal values (n = 292)

Only FGA (n = 35)

8.6% (3)

25.7% (9)

65.7% (23)

Combination FGA + SGA (n = 45)

2.2% (1)

28.9% (13)

68.9% (31)

Combination SGA (n = 19)

5.3% (1)

21.0% (4)

73.7% (14)

Only 1 SGA (n = 314)

6.7% (21)

22.6% (71)

70.7% (222)

Amisulpride (n = 26)

0% (0)

3.9% (1)

96.1% (25)

Aripiprazole (n = 3)

0% (0)

0% (0)

100% (3)

Clozapine (n = 54)

9.3% (5)

42.6% (23)

48.1% (26)

Risperidone (n = 75)

6.6% (5)

22.7% (17)

70.7% (53)

Quetiapine (n = 44)

11.4% (5)

9.1% (4)

79.5% (35)

Olanzapine (n = 112)

5.4% (6)

23.2% (26)

71.4% (80)